INTERMED.CAP.GRP.LS-,2625INTERMED.CAP.GRP.LS-,2625INTERMED.CAP.GRP.LS-,2625

INTERMED.CAP.GRP.LS-,2625

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪7.20 B‬EUR
‪569.26 M‬EUR
‪1.15 B‬EUR
‪271.96 M‬
Beta (1Y)
2.12
Employees (FY)
637
Change (1Y)
+55 +9.45%
Revenue / Employee (1Y)
‪1.95 M‬EUR
Net income / Employee (1Y)
‪926.22 K‬EUR

About INTERMEDIATE CAPITAL GROUP PLC ORD GBP0.2625


Sector
CEO
Benoît Laurent P. Durteste
Website
Headquarters
London
Founded
1988
ISIN
GB00BYT1DJ19
FIGI
BBG000Q6Q1B4
Intermediate Capital Group Plc provides flexible capital solutions to help companies develop and grow. It is a global alternative asset manager with over 30 years' history, investing across the capital structure. It operates across four asset classes: Structured and Private Equity, Private Debt, Real Assets, and Credit. The company was founded by Andrew Jackson, Thomas Hugh Bartlam, Jean-Loup Brousse de Gersigny, James Odgers, Andrew Coventon Phillips, and Paul J. Piper on March 23, 1988 and is headquartered in London, the United Kingdom.
Performance
Revenue to profit conversion
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
XS241367223
INTERMED.CAP 22/30
Yield to maturity
4.03%
Maturity date
Jan 28, 2030
XS211743590
INTERMED.CAP 20/27
Yield to maturity
3.59%
Maturity date
Feb 17, 2027

Explore more bonds 

Frequently Asked Questions


The current price of I2X2 is 25.2 EUR — it has increased by 0.81% in the past 24 hours. Watch INTERMED.CAP.GRP.LS-,2625 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange INTERMED.CAP.GRP.LS-,2625 stocks are traded under the ticker I2X2.
I2X2 stock has risen by 2.46% compared to the previous week, the month change is a −1.57% fall, over the last year INTERMED.CAP.GRP.LS-,2625 has showed a 40.16% increase.
We've gathered analysts' opinions on INTERMED.CAP.GRP.LS-,2625 future price: according to them, I2X2 price has a max estimate of 33.49 EUR and a min estimate of 26.90 EUR. Watch I2X2 chart and read a more detailed INTERMED.CAP.GRP.LS-,2625 stock forecast: see what analysts think of INTERMED.CAP.GRP.LS-,2625 and suggest that you do with its stocks.
I2X2 reached its all-time high on May 29, 2024 with the price of 28.6 EUR, and its all-time low was 6.0 EUR and was reached on Mar 19, 2020. View more price dynamics on I2X2 chart.
See other stocks reaching their highest and lowest prices.
I2X2 stock is 0.79% volatile and has beta coefficient of 2.12. Track INTERMED.CAP.GRP.LS-,2625 stock price on the chart and check out the list of the most volatile stocks — is INTERMED.CAP.GRP.LS-,2625 there?
Today INTERMED.CAP.GRP.LS-,2625 has the market capitalization of ‪7.13 B‬, it has increased by 4.31% over the last week.
Yes, you can track INTERMED.CAP.GRP.LS-,2625 financials in yearly and quarterly reports right on TradingView.
INTERMED.CAP.GRP.LS-,2625 is going to release the next earnings report on May 22, 2025. Keep track of upcoming events with our Earnings Calendar.
I2X2 earnings for the last half-year are 0.63 EUR per share, whereas the estimation was 0.98 EUR, resulting in a −36.35% surprise. The estimated earnings for the next half-year are 1.09 EUR per share. See more details about INTERMED.CAP.GRP.LS-,2625 earnings.
INTERMED.CAP.GRP.LS-,2625 revenue for the last half-year amounts to ‪486.76 M‬ EUR, despite the estimated figure of ‪588.84 M‬ EUR. In the next half-year revenue is expected to reach ‪629.66 M‬ EUR.
I2X2 net income for the last half-year is ‪183.15 M‬ EUR, while the previous report showed ‪306.04 M‬ EUR of net income which accounts for −40.15% change. Track more INTERMED.CAP.GRP.LS-,2625 financial stats to get the full picture.
INTERMED.CAP.GRP.LS-,2625 dividend yield was 3.85% in 2023, and payout ratio reached 46.45%. The year before the numbers were 6.37% and 78.89% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 25, 2024, the company has 637.00 employees. See our rating of the largest employees — is INTERMED.CAP.GRP.LS-,2625 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INTERMED.CAP.GRP.LS-,2625 EBITDA is ‪625.72 M‬ EUR, and current EBITDA margin is 60.99%. See more stats in INTERMED.CAP.GRP.LS-,2625 financial statements.
Like other stocks, I2X2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INTERMED.CAP.GRP.LS-,2625 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INTERMED.CAP.GRP.LS-,2625 technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INTERMED.CAP.GRP.LS-,2625 stock shows the buy signal. See more of INTERMED.CAP.GRP.LS-,2625 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.